These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 12584693

  • 1. The antitumor potential of bisphosphonates.
    Clézardin P.
    Semin Oncol; 2002 Dec; 29(6 Suppl 21):33-42. PubMed ID: 12584693
    [Abstract] [Full Text] [Related]

  • 2. Bisphosphonates: preclinical review.
    Green JR.
    Oncologist; 2004 Dec; 9 Suppl 4():3-13. PubMed ID: 15459425
    [Abstract] [Full Text] [Related]

  • 3. Antitumor effects of bisphosphonates.
    Green JR.
    Cancer; 2003 Feb 01; 97(3 Suppl):840-7. PubMed ID: 12548584
    [Abstract] [Full Text] [Related]

  • 4. Preclinical pharmacology of zoledronic acid.
    Green JR.
    Semin Oncol; 2002 Dec 01; 29(6 Suppl 21):3-11. PubMed ID: 12584689
    [Abstract] [Full Text] [Related]

  • 5. Bisphosphonates in preclinical bone oncology.
    Clézardin P, Benzaïd I, Croucher PI.
    Bone; 2011 Jul 01; 49(1):66-70. PubMed ID: 21145441
    [Abstract] [Full Text] [Related]

  • 6. Mechanisms of bisphosphonate effects on osteoclasts, tumor cell growth, and metastasis.
    Green JR, Clézardin P.
    Am J Clin Oncol; 2002 Dec 01; 25(6 Suppl 1):S3-9. PubMed ID: 12562045
    [Abstract] [Full Text] [Related]

  • 7. Bisphosphonates and cancer-induced bone disease: beyond their antiresorptive activity.
    Clézardin P, Ebetino FH, Fournier PG.
    Cancer Res; 2005 Jun 15; 65(12):4971-4. PubMed ID: 15958534
    [Abstract] [Full Text] [Related]

  • 8. Anti-tumor potential of bisphosphonates.
    Green JR.
    Med Klin (Munich); 2000 Oct 15; 95 Suppl 2():23-8. PubMed ID: 11089384
    [Abstract] [Full Text] [Related]

  • 9. Antitumor effects of bisphosphonates: promising preclinical evidence.
    Guise TA.
    Cancer Treat Rev; 2008 Oct 15; 34 Suppl 1():S19-24. PubMed ID: 18486348
    [Abstract] [Full Text] [Related]

  • 10. Bisphosphonates for the prevention of bone metastases.
    Coleman RE.
    Semin Oncol; 2002 Dec 15; 29(6 Suppl 21):43-9. PubMed ID: 12584694
    [Abstract] [Full Text] [Related]

  • 11. Pathophysiology of bone metastases: how this knowledge may lead to therapeutic intervention.
    Lipton A.
    J Support Oncol; 2004 Dec 15; 2(3):205-13; discussion 213-4, 216-7, 219-20. PubMed ID: 15328823
    [Abstract] [Full Text] [Related]

  • 12. Antitumor effects and anticancer applications of bisphosphonates.
    Morgan G, Lipton A.
    Semin Oncol; 2010 Oct 15; 37 Suppl 2():S30-40. PubMed ID: 21111246
    [Abstract] [Full Text] [Related]

  • 13. The potential role of bisphosphonates in prostate cancer.
    Oades GM, Coxon J, Colston KW.
    Prostate Cancer Prostatic Dis; 2002 Oct 15; 5(4):264-72. PubMed ID: 12627210
    [Abstract] [Full Text] [Related]

  • 14. Clinical value of bisphosphonates in cancer therapy.
    Lüftner D, Henschke P, Possinger K.
    Anticancer Res; 2007 Oct 15; 27(4A):1759-68. PubMed ID: 17649770
    [Abstract] [Full Text] [Related]

  • 15. Potential anticancer properties of bisphosphonates.
    Neville-Webbe HL, Gnant M, Coleman RE.
    Semin Oncol; 2010 Jun 15; 37 Suppl 1():S53-65. PubMed ID: 20682373
    [Abstract] [Full Text] [Related]

  • 16. Bisphosphonates in cancer therapy.
    Green JR.
    Curr Opin Oncol; 2002 Nov 15; 14(6):609-15. PubMed ID: 12409650
    [Abstract] [Full Text] [Related]

  • 17. Inhibitory effects of a new bisphosphonate, minodronate, on proliferation and invasion of a variety of malignant bone tumor cells.
    Kubo T, Shimose S, Matsuo T, Tanaka K, Yasunaga Y, Sakai A, Ochi M.
    J Orthop Res; 2006 Jun 15; 24(6):1138-44. PubMed ID: 16705696
    [Abstract] [Full Text] [Related]

  • 18. [The application advances of bisphosphonates in bone metastasis].
    Liang P.
    Zhongguo Gu Shang; 2008 Jun 15; 21(6):480-2. PubMed ID: 19108448
    [Abstract] [Full Text] [Related]

  • 19. Bisphosphonates induce apoptosis of stromal tumor cells in giant cell tumor of bone.
    Cheng YY, Huang L, Lee KM, Xu JK, Zheng MH, Kumta SM.
    Calcif Tissue Int; 2004 Jul 15; 75(1):71-7. PubMed ID: 15037971
    [Abstract] [Full Text] [Related]

  • 20. The backbone of progress--preclinical studies and innovations with zoledronic acid.
    Green JR, Guenther A.
    Crit Rev Oncol Hematol; 2011 Feb 15; 77 Suppl 1():S3-S12. PubMed ID: 21353178
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.